| Nov 14 |
InspireMD Third Quarter 2024 Earnings: US$0.16 loss per share (vs US$0.15 loss in 3Q 2023)
|
| Nov 13 |
InspireMD Inc (NSPR) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Rising Costs and ...
|
| Nov 12 |
InspireMD, Inc. (NSPR) Q3 2024 Earnings Call Transcript
|
| Nov 12 |
InspireMD GAAP EPS of -$0.16, revenue of $1.81M beats by $0.07M
|
| Nov 12 |
InspireMD Reports Third Quarter 2024 Financial Results and Provides Business Update
|
| Nov 12 |
Earnings Scheduled For November 12, 2024
|
| Nov 11 |
InspireMD Q3 2024 Earnings Preview
|
| Nov 8 |
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
| Nov 4 |
InspireMD to Report Third Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, November 12th
|
| Oct 21 |
One InspireMD Insider Raised Stake By 13% In Previous Year
|
